Molecule

Molecule

Private
SwitzerlandHealthcare & Life Scienceshttps://molecule.xyz

Last Round

Strategic

Dec 8, 2023

Total Funding Raised

$13.7M

Momentum Score

25 /100

Company Overview

Molecule is a biotechnology and web3 company that operates a decentralized marketplace to connect researchers with funding for scientific and drug development projects.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Investment Platforms, Tokenization, DAOs, Drug Discovery

Business Model

B2B2C

Customer Profile

Marketplace Commission, Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

decentralized scienceDeSciIP-NFTsIP tokenizationbiotech DAOsresearch fundingweb3 marketplacebiotech fundingdrug developmentDAO launchpadBioFiintellectual property marketplacealternative research fundinglongevity researchrare disease research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Molecule Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Molecule Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 8, 2023
SeedJun 27, 2022
Pre SeedJan 31, 2020

Key People

Founding team and executive leadership

Paul Kohlhaas

Chief Executive Officer

Executive Team

Kevin Noessler

Chief Product Officer, Managing Director (DeSci Entwicklungs GmbH)

Executive Team

Molecule Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 30, 2025

    Added ResearchHub, a scientific research startup, as a customer.

  • Sep 30, 2025

    Added Biome as a new customer.

Molecule Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Molecule Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Molecule's valuation, stock price, and market status.

Firmographic Details

HeadquartersSwitzerland
Employee Range30
Year Founded2020
Last FundingDec 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.